Stay updated with breaking news from Afyx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
First Trust Small Cap Core AlphaDEX Fund (NASDAQ:FYX – Get Rating) announced a quarterly dividend on Thursday, March 24th, Zacks reports. Stockholders of record on Monday, March 28th will be given a dividend of 0.112 per share on Thursday, March 31st. This represents a $0.45 annualized dividend and a dividend yield of 0.48%. The ex-dividend […]
First Trust Small Cap Core AlphaDEX Fund (NASDAQ:FYX – Get Rating) was the target of a significant decrease in short interest in the month of February. As of February 28th, there was short interest totalling 2,900 shares, a decrease of 58.0% from the February 13th total of 6,900 shares. Based on an average daily trading […]
On Tuesday, SoFi announced the launch of the SoFi Weekly Dividend ETF (NYSE: WKLY), the first equity ETF designed to provide a weekly dividend payment to shareholders. WKLY joins a SoFi ETF family that includes the SoFi Weekly Income ETF (NYSE: TGIF), which launched in 2020 and was the first fixed income ETF to offer a weekly distribution to fund shareholders. WKLY seeks to track the performance of the SoFi Sustainable Dividend Index, which is made up of large- and mid-cap companies in both the U.S. and developed international markets that meet a robust set of sustainable dividend filters....
(0) Novel mucoadhesive patch adheres to wet tissue surfaces and enables targeted, localized delivery of therapeutic to lesions inside the mouth AFYX Therapeutics ("AFYX"), a clinical stage biopharmaceutical company developing innovative approaches to treat mucosal diseases, today announced that a study of the Rivelin Clobetasol patch ("Rivelin-CLO"), a novel adhesive patch technology designed to deliver a therapeutic agent to wet tissue surfaces, was featured in the March issue of The European Journal of Oral Sciences. This is the first study to show the successful transmucosal delivery...